Trials / Completed
CompletedNCT00453128
Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients
Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (planned)
- Sponsor
- Sociedade Galega de Reumatoloxía · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease.
Detailed description
The diagnostic usefulness of screening for hyperparathyroidism, hemochromatosis, hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate (CPPD) deposition disease is uncertain. Patients diagnosed with CPPD deposition disease were compared to patients with rheumatoid arthritis and psoriatic arthritis over a 9-year period. All patients were prospectively followed for at least 12 months. Serum calcium, phosphorus, alkaline phosphatase, thyroid-stimulating hormone, ferritin, iron, and total iron binding capacity were determined in all patients.
Conditions
Timeline
- Start date
- 1997-01-01
- Completion
- 2006-12-01
- First posted
- 2007-03-28
- Last updated
- 2007-03-28
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00453128. Inclusion in this directory is not an endorsement.